Showing results (351-360 of 408) with videos related to
Sort By:
Pageof 41
BJOG : an International Journal of Obstetrics and Gynaecology|July 20, 2000
The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infantsO Baud, V Zupan, T Lacaze-Masmonteil, et al.Human Reproduction (Oxford, England)|April 29, 2006
A randomized double-blind controlled study on the efficacy of laser zona pellucida thinning on live birth rates in cases of advanced female ageN Frydman, S Madoux, L Hesters, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropinsD de Ziegler, C Bergeron, C Cornel, et al.Fetal Diagnosis and Therapy|May 1, 1995
Fetal-maternal hydrops syndrome in human parvovirus infectionY Ville, A de Gayffier, F Brivet, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 8, 2006
[Vaginal mesh extrusion after transvaginal repair of cystocele using a prosthetic mesh: Treatment and functional outcomes]X Deffieux, C Huel, R de Tayrac, et al.Annales D'Endocrinologie|July 1, 2005
[The Paris experience in preimplantation genetic diagnosis: evaluation after the first births]N Frydman, S Romana, P Ray, et al.Contraception, Fertilite, Sexualite (1992)|July 1, 1997
[Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone]J L Pouly, S Bassil, R Frydman, et al.Facts, Views & Vision in Obgyn|October 13, 2016
Tadalafil for Endometrial Growth in Clomiphene Citrate stimulated cycles in an IUI programma: A pilot studyD H Mendez Lozano, M V Lenero, R L Gonzalez, et al.Human Reproduction (Oxford, England)|February 1, 1987
Morphological anomalies in the placentae of IVF pregnancies: preliminary report of a multicentric studyY Englert, M C Imbert, E Van Rosendael, et al.Human Reproduction (Oxford, England)|October 1, 1996
Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesteroneJ L Pouly, S Bassil, R Frydman, et al.Pageof 41